Three local biopharmaceutical companies have cleared important hurdles in their race to find a more effective treatment for age-related macular degeneration, the leading cause of blindness in adults.
Three local biopharmaceutical companies have cleared important hurdles in their race to find a more effective treatment for age-related macular degeneration, the leading cause of blindness in adults.
